Business Name: |
Chudoba Ondrej MD |
Contact Person: |
Ondrej Chudoba |
Address: |
1414 Main St, Melrose Park, Illinois 60160 |
Phone Number: |
(708) 410-0615 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Meeks Steve MD - Melrose Park, IL 60160 Mehta Ashima D MD - Melrose Park, IL 60160 Patodia Shobhana MD - Melrose Park, IL 60160 Kim Kee MD - Melrose Park, IL 60160 West Suburban Head & Neck - Melrose Park, IL 60160 Furlin Joseph J MD - Melrose Park, IL 60160 Giacchino Joseph L MD - Melrose Park, IL 60160 Westside Medical Assoc - Melrose Park, IL 60160 Special Care Orthopedics - Melrose Park, IL 60160 Westside Medical - Melrose Park, IL 60160 Bailey Larry MD - Melrose Park, IL 60160 James Thomas MD - Melrose Park, IL 60160 Gafoor Mohammad A MD - Melrose Park, IL 60160 Kassam Zahra M MD - Melrose Park, IL 60160 Rathi Kokeela R MD - Melrose Park, IL 60160 Flores-Stadler Elbio M MD - Melrose Park, IL 60160 George Alphonsa T MD - Melrose Park, IL 60160 Fong Nepenthe I MD - Melrose Park, IL 60160 Maturen Katherine E MD - Melrose Park, IL 60160 Choudhry Iffat A MD - Melrose Park, IL 60160 |
The company Chudoba Ondrej MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Chudoba Ondrej MD, and the business now earns $500.000 to $999.999 per annum.
Chudoba Ondrej MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Chudoba Ondrej MD, please call Ondrej Chudoba with the phone number (708) 410-0615 or visit its single location at 1414 Main St in Melrose Park, Illinois 60160.
The location of the single location can also be found using the coordinates 41.89039,-87.85124.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.